The DayOne Accelerator has helped launch more than 60 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies below.
Latest update: 09/09/2025
Portfolio
In the spotlight
Oncoustics
Oncoustics applies AI to raw sound signals on low-cost ultrasound devices turning these into powerful virtual biopsy tools that will democratize diagnostics.
FindMeCure / Trialhub
TrialHub: Insights that turn trials into treatments.
Theremia
Theremia is an AI-driven platform that optimizes drug development by ensuring pharmaceutical companies create the right drug for the right population subgroups.
Risklick
Revolutionizing clinical trial protocol with first-in-class AI software.
Senseera Health
Senseera’s goal is to transform precision medicine for every patient and pioneer liver diagnostics through groundbreaking chromatin epigenomics.
Portfolio
Company
Therapeutic areas
Country
Funding Stage
Development stage
aimed analytics
Therapeutic area: z-Other
Country: Germany
Funding Stage: Seed
Development stage: Design & development
AI-powered, no-code platform that helps biomedical researchers analyze omics data quickly and accurately.
Visit website
z-Other
Germany
Seed
Design & development
Albus Health
Therapeutic area: Cardiovascular diseases, Chronic diseases, Neurology, Pediatrics, Pulmonology, Respiratory Diseases, Sleep
Country: United Kingdom
Funding Stage: Seed
Development stage: Commercial launch
Contactless bedside multi-sensor device that continuously tracks respiratory and environmental health metrics for clinical trials.
Visit website
Cardiovascular diseases, Chronic diseases, Neurology, Pediatrics, Pulmonology, Respiratory Diseases, Sleep
United Kingdom
Seed
Commercial launch
AllesHealth
Therapeutic area: Chronic diseases, Mental Health
Country: Switzerland
Funding Stage: Seed
Development stage: Regulatory approval & launch prep
AI-powered EHR and telehealth platform helping patients and providers manage healthcare affordably.
Visit website
Chronic diseases, Mental Health
Switzerland
Seed
Regulatory approval & launch prep
Ancora.ai
Therapeutic area: Oncology
Country: Switzerland
Funding Stage: Seed
Development stage: Regulatory approval & launch prep
AI platform matching cancer patients to personalized clinical trials quickly and free.
Visit website
Oncology
Switzerland
Seed
Regulatory approval & launch prep
Areltys
Therapeutic area: Oncology
Country: France
Funding Stage: Pre seed
Development stage: Design & development
Digital platform connecting cancer patients to innovative treatments, especially radioligand therapies worldwide.
Visit website
Oncology
France
Pre seed
Design & development
Avegen Limited
Therapeutic area: Cardiovascular diseases, Infectious diseases, Mental Health
Country: United Kingdom
Funding Stage: Seed
Development stage: Commercial launch
Digital health platforms for patient support, digital therapeutics and streamlined clinical workflows.
Visit website
Cardiovascular diseases, Infectious diseases, Mental Health
United Kingdom
Seed
Commercial launch
BioT Medical
Therapeutic area: z-Other
Country: Israel
Funding Stage: Serie A
Development stage: Commercial launch
Cloud platform turning medical devices into secure, connected remote care solutions.
Visit website
z-Other
Israel
Serie A
Commercial launch
BowHead
Therapeutic area: Chronic diseases, Gastroenterology, Oncology
Country: Canada
Funding Stage: Seed
Development stage: Design & development
AI-powered platform matching patients to personalized cancer trials using secure health data.
Visit website
Chronic diseases, Gastroenterology, Oncology
Canada
Seed
Design & development
Briya
Therapeutic area: z-Other
Country: Israel
Funding Stage: Serie B
Development stage: Commercial launch
AI research platform turning real-world medical data into secure, compliant insights.
Visit website
z-Other
Israel
Serie B
Commercial launch
C. Light Technologies
Therapeutic area: Brain Health, Neurology, Ophtalmology
Country: United States
Funding Stage: Seed
Development stage: Commercial launch
Neurotech solutions using retinal eye-tracking and AI to detect neurological diseases.
Visit website
Brain Health, Neurology, Ophtalmology
United States
Seed
Commercial launch
